Building on landmark Nature Biotechnology findings, Nutromics secures AU$3 million in a AU$11.2 million consortium to ...

Sepsis is a medical emergency. Identify early signs, understand the Hour-1 bundle, and see how rapid intervention saves lives ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

A new study evaluated which model the Centers for Disease Control and Prevention and Centers for Medicare & Medicaid Services (CMS) should use to measure sepsis management and outcomes. It found that ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

The management of sepsis in the critical care setting remains a formidable challenge, demanding an integrated approach that combines early detection, prompt therapeutic intervention and continuous ...

The 2 new publications are a major overhaul of sepsis management for adults and children. HealthDay News — International guidelines are presented for the treatment of adults and children with sepsis ...

Cell-based therapies can potentially restore normal immune function and treat organ failure in sepsis. Medical researchers have embarked on clinical trials and pre-clinical studies to investigate the ...

An increasing incidence of sepsis in the U.S., which hovers around 1.6 million cases and is estimated to cost $15 billion per year, has healthcare organizations worried. To stem the tide of cases and ...

In a healthcare world in which amazing things are increasingly possible — surgery through just a few tiny incisions, successful replacements of entire organs, treatment of once-fatal infections — ...

This is the fourth article in a Health Affairs Forefront short series “Understanding And Addressing Pre-Hospital Diagnostic Delays.” As the introductory article, “Building the Evidence to Assure ...

HENDERSON, Nev., Sept. 13, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is hosting a Key Opinion Leader ("KOL") roundtable ...